Pharmaceutical

Iovance’s PDUFA date for lifileucel pushed due to FDA backlog

The FDA pushed lifileucel’s PDUFA date from November this year to 24 February 2024 citing resource constraints.

Sep 15, 2023 - 20:00
Iovance’s PDUFA date for lifileucel pushed due to FDA backlog
The FDA pushed lifileucel’s PDUFA date from November this year to 24 February 2024 citing resource constraints.
Read the original article

Tags:

Previous Article

Remote Patient Monitoring market will reach $760m by 2030

Next Article

argenx wins EMA CHMP nod for subcutaneous Vyvgart in myasthenia gravis

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Telehealth companies that provide abortion pills grapple with regulatory uncertainty 

Telehealth companies that provide abortion pills grappl...

Apr 25, 2023

STAT+: Pharmalittle: U.S. Chamber and feds clash on Medicare price negotiation; South Africa probes J&J over TB-drug pricing

STAT+: Pharmalittle: U.S. Chamber and feds clash on Med...

Sep 18, 2023

Generics expected to improve access for patients with idiopathic pulmonary fibrosis

Generics expected to improve access for patients with i...

Sep 27, 2023